Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Thiamine Supplementation Guidelines for Alcoholic Patients

Initial Treatment Strategy

  • All alcoholic patients should receive thiamine 100-300 mg/day intravenously for 3-5 days upon admission, followed by oral maintenance therapy of 50-100 mg/day for 2-3 months, as recommended by the Clinical Nutrition guideline 1, 2
  • Administer thiamine 100-300 mg IV daily for 3-5 days immediately upon admission without waiting for laboratory confirmation, according to the Clinical Nutrition guideline 1
  • For suspected or proven Wernicke's encephalopathy, escalate to 500 mg IV three times daily, as recommended by the Clinical Nutrition guideline 1

Critical Timing Consideration

  • Always administer thiamine BEFORE any glucose-containing IV fluids, as glucose administration can precipitate acute Wernicke's encephalopathy in thiamine-depleted patients, as stated in the Clinical and Molecular Hepatology guideline 2
  • This is a critical pitfall that can cause irreversible neurological damage, according to the Clinical and Molecular Hepatology guideline 2

Route Selection

  • IV route is mandatory for initial treatment in alcoholic patients due to severely impaired gastrointestinal absorption from chronic alcohol ingestion, as recommended by the Clinical Nutrition guideline 1
  • IV thiamine 250 mg is specifically required to manage encephalopathy effectively, according to the Clinical Nutrition guideline 1

Maintenance Therapy

  • Continue oral thiamine 50-100 mg/day for 2-3 months after resolution of acute symptoms, as recommended by the Clinical Nutrition and Clinical and Molecular Hepatology guidelines 1, 2
  • For prevention of Wernicke's encephalopathy: 100-300 mg/day for 4-12 weeks, according to the Clinical and Molecular Hepatology guideline 2
  • For established Wernicke's encephalopathy: 100-500 mg/day for 12-24 weeks, as recommended by the Clinical and Molecular Hepatology guideline 2

Clinical Situation-Specific Dosing

  • Standard dose: 100-300 mg/day IV for 3-4 days, then transition to oral, for alcohol withdrawal syndrome, as recommended by the Clinical Nutrition and Clinical and Molecular Hepatology guidelines 1, 2
  • 500 mg IV three times daily until etiology is clarified, for encephalopathy of uncertain etiology, according to the Clinical Nutrition guideline 1
  • 10 mg/day orally for one week, followed by 3-5 mg daily for at least 6 weeks, for outpatient/mild deficiency, as recommended by the Clinical Nutrition guideline 1

Safety Profile

  • Thiamine has no established upper limit and excess is simply excreted in urine, according to the Clinical Nutrition guideline 1
  • Doses >400 mg may cause mild nausea, anorexia, or ataxia, but these are not dangerous, as stated in the Clinical Nutrition guideline 1

Special Populations

  • Use the same aggressive dosing (100-300 mg IV daily) as liver disease increases thiamine deficiency risk, according to the Clinical and Molecular Hepatology guideline 2
  • 300 mg IV before initiating nutrition therapy, then 200-300 mg IV daily for at least 3 more days, for refeeding syndrome risk, as recommended by the Clinical Nutrition guideline 1
  • 100 mg/day to replace losses, for continuous renal replacement therapy, according to the Clinical Nutrition guideline 1

REFERENCES